46 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
11
The N-Terminal T-T Motif of a Third-Generation HIV-1 Fusion Inhibitor Is Not Required for Binding Affinity and Antiviral Activity.
Peking Union Medical College
15
Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with HIV-1 surface glycoprotein.
Ibitecs, Cea
140
Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screening.
Bryn Mawr College
1
Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist.
Glaxosmithkline
3
Structure-directed discovery of an inhibitor of the binding of HIV GP120 to the CD4 receptor
TBA
15
Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor.
University of Illinois At Urbana-Champaign
1
Rational Design of Sulfonyl-γ-AApeptides as Highly Potent HIV-1 Fusion Inhibitors with Broad-Spectrum Activity.
University of South Florida
2
Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors.
Lindsley F. Kimball Research Institute
8
Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors.
Tokyo Medical and Dental University
1
Recent research results have converted gp120 binders to a therapeutic option for the treatment of HIV-1 infection. A medicinal chemistry point of view.
University of Siena
34
Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements.
Moscow State University
12
Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-Mimics.
University of Pennsylvania
18
Hybrids of Small-Molecule CD4 Mimics with Polyethylene Glycol Units as HIV Entry Inhibitors.
Tokyo Medical and Dental University (Tmdu)
5
Suitable fusion of N-terminal heptad repeats to achieve covalently stabilized potent N-peptide inhibitors of HIV-1 infection.
Nankai University
1
Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide.
Cornell University
21
Soluble-type small-molecule CD4 mimics as HIV entry inhibitors.
Tokyo Medical and Dental University
4
Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
University of Pennsylvania
34
Investigation of the molecular characteristics of bisindole inhibitors as HIV-1 glycoprotein-41 fusion inhibitors.
Touro University-California
2
Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors.
Instituto De Qu£Mica M£Dica (Iqm-Csic)
2
Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1.
Duke University Medical Center
1
De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.
Beijing Institute of Pharmacology & Toxicology
3
Synthesis and biological evaluation of water-soluble derivatives of chiral gossypol as HIV fusion inhibitors targeting gp41.
Renmin Hospital of Wuhan University
3
Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir.
TBA
100
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use
Abbvie
158
Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
Array Biopharma
33
Benzofurans substituted with primary benzamide as HCV inhibitors
Bristol Myers Squibb
3
Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor ß/d (PPARß/d) in the brain.
Case Western Reserve University School of Medicine
20
Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their use for imaging of thrombi
Piramal Imaging
84
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
Merck Sharp & Dohme
3
Discovery of Novel Allosteric Eg5 Inhibitors Through Structure-Based Virtual Screening.
Southern Research Institute
8
Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
Boehringer Ingelheim International
13
Design, Synthesis and Biological Evaluation of Imidazo[1,2-a]pyridine Derivatives as Novel DPP-4 Inhibitors.
China Pharmaceutical University
3
Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanism.
Novartis